Clinical use of fructosamine in islet transplantation

Cell Transplantation

Volumn 18, Issue 4, 2009, Pages 453-458

  Tharavanij, Thipaporn ^a,b   Froud, Tatiana ^a,c   Leitao, Cristiane B ^a   Baidal, David A ^a   Paz Pabon, Charlotte N ^a   Shari, Messinger ^a,c   Cure, Pablo ^a   Bernetti, Karina ^a   Ricordi, Camillo ^a,c   Alejandro, Rodolfo ^a,c  

^a UNIVERSITY OF MIAMI   (United States)

^b THAMMASAT UNIVERSITY   (Thailand)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Fructosamine; Graft dysfunction; HbA1C; Islet transplantation

Indexed keywords

C PEPTIDE; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CAPILLARY BLOOD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; MALE; OUTCOME ASSESSMENT; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; TRANSPLANTATION, HOMOLOGOUS;

EID: 67651247644     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909788809848     Document Type: Article

References (27)

1. Baidal, D. A.; Froud, T.; Ferreira, J. V.; Khan, A.; Alejandro, R.; Ricordi, C. The bag method for islet cell infusion. Cell Transplant. 12(7):809-813; 2003.
2. Cefalu, W. T.; Parker, T. B.; Johnson, C. R. Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients. Diabetes Care 11(8):662-664; 1988.
3. Cure, P.; Pileggi, A.; Froud, T.; Messinger, S.; Faradji, R. N.; Baidal, D. A.; Cardani, R.; Curry, A.; Poggioli, R.; Pugliese, A.; Betancourt, A.; Esquenazi, V.; Ciancio, G.; Selvaggi, G.; Burke, 3rd, G. W.; Ricordi, C.; Alejandro, R. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation 85(6):801-812; 2008.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14):977-986; 1993.
5. Dungan, K. M.; Buse, J. B.; Largay, J.; Kelly, M. M.; Button, E. A.; Kato, S.; Wittlin, S. 1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 29(6):1214-1219; 2006.
6. Faradji, R. N.; Monroy, K.; Riefkohl, A.; Lozano, L.; Gorn, L.; Froud, T.; Cure, P.; Baidal, D.; Ponte, G.; Messinger, S.; Mastrototaro, J.; Ricordi, C.; Alejandro, R. Continuous glucose monitoring system for early detection of graft dysfunction in allogenic islet transplant recipients. Transplant. Proc. 38(10):3274-3276; 2006.
7. Froud, T.; Faradji, R. N.; Gorn, L.; Monroy, K.; Paz, C.; Baidal, D. A.; Ponte, G.; Cure, P.; Poggioli, R.; Pileggi, A.; Ricordi, C.; Alejandro, R. Dapsone-induced artifactual a1c reduction in islet transplant recipients. Transplantation 83(6):824-825; 2007.
8. Froud, T.; Ricordi, C.; Baidal, D. A.; Hafiz, M. M.; Ponte, G.; Cure, P.; Pileggi, A.; Poggioli, R.; Ichii, H.; Khan, A.; Ferreira, J. V.; Pugliese, A.; Esquenazi, V. V.; Kenyon, N. S.; Alejandro, R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am. J. Transplant. 5(8):2037-2046; 2005.
9. Froud, T.; Yrizarry, J. M.; Alejandro, R.; Ricordi, C. Use of D-STAT to prevent bleeding following percutaneous transhepatic intraportal islet transplantation. Cell Transplant. 13(1):55-59; 2004.
10. Geiger, M. C.; Ferreira, J. V.; Hafiz, M. M.; Froud, T.; Baidal, D. A.; Meneghini, L. F.; Ricordi, C.; Alejandro, R. Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation. Cell Transplant. 14(2-3):77-84; 2005.
11. Goldstein, D. E.; Little, R. R.; Lorenz, R. A.; Malone, J. I.; Nathan, D.; Peterson, C. M.; Sacks, D. B. Tests of glycemia in diabetes. Diabetes Care 27(7):1761-1773; 2004.
12. Gorn, L.; Faradji, R. N.; Messinger, S.; Monroy, K.; Baidal, D. A.; Froud, T.; Mastrototaro, J.; Ricordi, C.; Alejandro, R. Impact of islet transplantation on glycemic control as evidenced by a continuous glucose monitoring system. J. Diabetes Sci. Technol. 2(2):221-228; 2008.
13. Guyatt, G. H.; Oxman, A. D.; Ali, M.; Willan, A.; McIlroy, W.; Patterson, C. Laboratory diagnosis of iron-deficiency anemia: An overview. J. Gen. Intern. Med. 7(2):145-153; 1992.
14. Hafiz, M. M.; Faradji, R. N.; Froud, T.; Pileggi, A.; Baidal, D. A.; Cure, P.; Ponte, G.; Poggioli, R.; Cornejo, A.; Messinger, S.; Ricordi, C.; Alejandro, R. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation 80(12):1718-1728; 2005.
15. Howey, J. E.; Bennet, W. M.; Browning, M. C.; Jung, R. T.; Fraser, C. G. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: Use of data on biological variation. Diabetes Med. 6(9):793-796; 1989.
16. Inaba, M.; Okuno, S.; Kumeda, Y.; Yamada, S.; Imanishi, Y.; Tabata, T.; Okamura, M.; Okada, S.; Yamakawa, T.; Ishimura, E.; Nishizawa, Y.; Osaka CKD Expert Research Group. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 18(3):896-903; 2007.
17. Jones, I. R.; Owens, D. R.; Williams, S.; Ryder, R. E.; Birtwell, A. J.; Jones, M. K.; Gicheru, K.; Hayes, T. M. Glycosylated serum albumin: An intermediate index of diabetic control. Diabetes Care 6(5):501-503; 1983.
18. Koenig, R. J.; Peterson, C. M.; Jones, R. L.; Saudek, C.; Lehrman, M.; Cerami, A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N. Engl. J. Med. 295(8):417-420; 1976.
19. Narbonne, H.; Renacco, E.; Pradel, V.; Portugal, H.; Vialettes, B. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes? Diabetes Metab. 27(5 Pt. 1):598-603; 2001.
20. Obuchowski, N. A. Nonparametric analysis of clustered ROC curve data. Biometrics 53(2):567-578; 1997.
21. Poggioli, R.; Faradji, R. N.; Ponte, G.; Betancourt, A.; Messinger, S.; Baidal, D. A.; Froud, T.; Ricordi, C.; Alejandro, R. Quality of life after islet transplantation. Am. J. Transplant. 6(2):371-378; 2006.
22. Ponte, G. M.; Pileggi, A.; Messinger, S.; Alejandro, A.; Ichii, H.; Baidal, D. A.; Khan, A.; Ricordi, C.; Goss, J. A.; Alejandro, R. Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant. 16(6):595-607; 2007.
23. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Bigam, D.; Alfadhli, E.; Kneteman, N. M.; Lakey, J. R.; Shapiro, A. M. Five-year follow-up after clinical islet transplantation. Diabetes 54(7):2060-2069; 2005.
24. Shapiro, A. M.; Ricordi, C.; Hering, B. J.; Auchincloss, H.; Lindblad, R.; Robertson, R. P.; Secchi, A.; Brendel, M. D.; Berney, T.; Brennan, D. C.; Cagliero, E.; Alejandro, R.; Ryan, E. A.; DiMercurio, B.; Morel, P.; Polonsky, K. S.; Reems, J. A.; Bretzel, R. G.; Bertuzzi, F.; Froud, T.; Kandaswamy, R.; Sutherland, D. E.; Eisenbarth, G.; Segal, M.; Preiksaitis, J.; Korbutt, G. S.; Barton, F. B.; Viviano, L.; Seyfert-Margolis, V.; Bluestone, J.; Lakey, J. R. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355(13):1318-1330; 2006.
25. Starkman, H. S.; Wacks, M.; Soeldner, J. S.; Kim, A. Effect of acute blood loss on glycosylated hemoglobin determinations in normal subjects. Diabetes Care 6(3):291-294; 1983.
26. Tarim, O.; Kucukerdogan, A.; Gunay, U.; Eralp, O.; Ercan, I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr. Int. 41(4):357-362; 1999.
27. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131):837-853; 1998.